highly significantp < 0.001
For Global Health, early-stage scores rose from 58.8 ± 14.1 at baseline to 64.4 ± 14.8 at six months (Δ +5.6 points), while advanced-stage scores increased from 59.1 ± 14.3 to 65.3 ± 14.9 (Δ +6.2 points); both within-stage time effects were highly significant ( p < 0.001) and the stage × time interaction was non-significant ( p = 0.41), confirming parallel recovery.